Padel, Rafael L.
HRN: 26-57-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/29/2025
02/05/2025
IVT
500 Mg
Q 8h
Blunt Abdominal Injury
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes